12/09/2019
Meet Dr. Saravanakumar Dhakshinamoorthy (SK) , a scientist by training, and has worked at leading drug organizations across geographies & cultures, in positions of varied responsibilities. He has led interdisciplinary drug discovery teams and provided leadership for discovery programs spanning multiple therapeutic areas including oncology, inflammation, metabolic disorders & anti-infectives.
SK has also authored several high impact scientific publications and also is a member of the Senior Management team and his core responsibilities include innovation, operations, and customer relationship. Currently, SK oversees the integrated drug discovery portfolio and site operations at Jubilant Biosys Ltd., India.
SK considers PGPEM as a structured platform where learning from seasoned mentors from diverse industries will help bridge the gap in his management skills and enhance his knowledge. He likes to share his experiences of persevering in an industry that is high on investment with very limited probability of success, and a longer lead time for ROI with his cohorts.
Some of his past affiliations include Baylor college of Medicine, USA; Institute of Molecular & Cell Biology, Singapore; Aurigene Discovery Technologies, India; Albany Molecular Research Inc., Singapore.
https://www.iimb.ac.in/programmes/pgpem